TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
João Vinagre(Universidade do Porto), Paula Soares(Universidade do Porto)
Cited by 19
Related Papers
The mTOR Signalling Pathway in Human Cancer
|International Journal of Molecular Sciences|2012|831
AZD1480 Blocks Growth and Tumorigenesis of RET- Activated Thyroid Cancer Cell Lines
|PLoS ONE|2012|24
In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp
|Endocrine Related Cancer|2011|13
Budget-Constrained Collaborative Renewable Energy Forecasting Market
|IEEE Transactions on Sustainable Energy|2025|5
Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma
|International Journal of Molecular Sciences|2024|3